![](/img/cover-not-exists.png)
275PEfficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience
Heong, V Y M, Lim, Y W, Lee, S C, Ow, S, Lim, S E, Ong, P Y, Low, J, Ng, J, Ilancheran, A, Tong, P, Lim, D, Tan, DVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy436.022
Date:
November, 2018
File:
PDF, 72 KB
2018